‘Exciting’ clinical results offer hope for new class of MS therapies

[Prot]

Early results from a clinical trial suggest that a common diabetes drug taken with an antihistamine can partially repair damage in the nervous system that drives disability in multiple sclerosis.

While the effect was too small for patients to notice a benefit after six months, tests did reveal improvements in nerve function, raising hopes that damage to the protective coatings around nerve fibres might be reversed with drugs.




“I feel like we’re at this precipice of a new class of therapies for MS and that’s why this is exciting,” said Dr Nick Cunniffe, a neurologist at the University of Cambridge who led the CCMR Two trial.


Only registered and activated users can see links., Click Here To Register...

[agate]

That really sounds like a promising avenue to explore. It looks as if another new drug is on the horizon--another one that slows down the disease process but doesn't make the patient feel any better. Far better than nothing. Back when I was diagnosed, there was nothing being offered. People could be put on steroids sometimes and that was the only help available.

Thank you for finding this, Tim!

[Virginia]

Thanks Tim, this sounds interesting. A little late for many of us but I am hoping for better things for young people when it comes to MS.